ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE recommends Novartis’ wet AMD drug Beovu pharmatimes
December 16, 2020The UK’s National Institute for Health and Care Excellence (NICE) has recommended Novartis’ anti-VEGF treatment Beovu (brolucizumab) for routine NHS use in wet age-related degeneration (AMD) patients.
Pharma Sources Insight January 2025
